🚀 $VKTX Surges on Data That Could Reshape the Obesity Drug Market Viking Therapeutics ($VKTX) just dropped genuinely exciting data — and this time it's not hy

🚀 $VKTX Surges on Data That Could Reshape the Obesity Drug Market Viking Therapeutics ($VKTX) just dropped genuinely exciting data — and this time it's not hype, it's numbers. The headline result: In its VK2735-102 maintenance study, patients who took weekly VK2735 for 21 weeks lost 16–19% of the…